Results 51 to 60 of about 970,987 (213)

Determinants of Anemia among HIV-Positive Children on Highly Active Antiretroviral Therapy Attending Hospitals of North Wollo Zone, Amhara Region, Ethiopia, 2019: A Case-Control Study

open access: yesAnemia, 2020
Introduction. Anemia is one of the most commonly observed hematological abnormalities and an independent poor prognostic marker of HIV disease. The rate of progression and mortality in this subgroup of patients is high compared to nonanemic patients. WHO
Biruk Beletew   +4 more
doaj   +1 more source

Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up [PDF]

open access: yes, 2016
Primary autoimmune hemolytic anemia (P-AIHA) is a relatively uncommon and hetereogeneous disease characterized by the destruction of red blood cells due to anti-erythrocyte autoantibodies (AeAbs) in the absence of an associated disease [1–3].
ARMIENTO, DANIELE   +15 more
core   +1 more source

Validation of the WHO Hemoglobin Color Scale Method

open access: yesAnemia, 2014
This study was carried out to evaluate the diagnostic accuracy of WHO color scale in screening anemia during blood donor selection in Sri Lanka. A comparative cross-sectional study was conducted by the Medical Laboratory Sciences Unit of University of ...
Leeniyagala Gamaralalage Thamal Darshana   +1 more
doaj   +1 more source

Pregnancy Outcomes among Patients with Sickle Cell Disease in Brazzaville

open access: yesAnemia, 2020
Introduction. Sickle cell disease (SCD) is one of the most common genetic diseases in the world. It combines, in its homozygous form, chronic hemolytic anemia, vasoocclusive complications, and susceptibility to infections.
F. O. Galiba Atipo Tsiba   +6 more
doaj   +1 more source

Preclinical correction of human Fanconi anemia complementation group A bone marrow cells using a safety-modified lentiviral vector. [PDF]

open access: yes, 2010
One of the major hurdles for the development of gene therapy for Fanconi anemia (FA) is the increased sensitivity of FA stem cells to free radical-induced DNA damage during ex vivo culture and manipulation.
Adair, J   +10 more
core   +2 more sources

Luspatercept for the treatment of lower-risk myelodysplastic syndrome with SF3B1 mutation: a real-world single-center research in China

open access: yesHematology
Background Luspatercept, approved by the FDA and EMA for patients with transfusion-dependent lower-risk myelodysplastic syndrome (LR-MDS) unresponsive to erythropoiesis-stimulating agents (ESAs), lacks extensive real-world data, particularly in China ...
Weiru Liang   +21 more
doaj   +1 more source

Leucocytosis and Asymptomatic Urinary Tract Infections in Sickle Cell Patients at a Tertiary Hospital in Zambia

open access: yesAnemia, 2020
Sickle cell anaemia (SCA) is an inherited disease resulting from mutations in the β-globin chain of adult haemoglobin that results in the formation of homozygous sickle haemoglobin.
Taonga Musonda   +7 more
doaj   +1 more source

Pregnant Mothers\u27 Knowledge, Attitude and Practice Towards Preventions of Iron Deficiency Anemia in Harar Town, Ethiopia [PDF]

open access: yes, 2019
Low maternal risk perception, poor dietary practice and low adherence to iron and folate tablets among pregnant women are major contributors for higher burden of anemia.
Abdu, A. O. (Abdu)   +1 more
core  

Determinants of Anemia among Children Aged 6–59 Months Living in Kilte Awulaelo Woreda, Northern Ethiopia

open access: yesAnemia, 2014
Introduction. The aim of this study was to determine the prevalence of anemia and determinant factors among children aged 6–59 months living in Kilte Awulaelo Woreda, eastern zone. Method.
Gebremedhin Gebreegziabiher   +2 more
doaj   +1 more source

Blood Transfusion Frequency and Indications in Yemeni Children with Sickle Cell Disease

open access: yesAnemia, 2020
Background. Blood transfusion is an essential component in the care of patients with sickle cell disease (SCD), but it might be associated with serious acute and delayed complications.
Abdul-Wahab M. Al-Saqladi   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy